Fulcrum therapeutics to participate at the upcoming svb securities global biopharma conference

Cambridge, mass., feb. 08, 2023 (globe newswire) -- fulcrum therapeutics, inc.® (nasdaq: fulc), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that management will participate in a virtual presentation at the svb securities global biopharma conference on wednesday, february 15, 2023 at 10:00 am et.
FULC Ratings Summary
FULC Quant Ranking